Clinical Trials · NCT00691158
A Study of the Functional Magnetic Resonance Imaging Response to Leptin and Pramlintide
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Oregon Health and Science University
- Enrollment
- 10
- Start date
- Jan 2006
- Locations
- 1 site, United States
- Primary endpoint
- To measure the fMRI response in the hypothalamus and brainstem, and whole brain, to intravenous leptin, pramlintide, combination leptin and pramlintide, and saline control.